David Garcia
Family · Pasadena, TXNPI 1902346570
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 287 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,890 and has fallen 97.5% since, to $73 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$918
- Lilly USA, LLC$606
- Bayer$316
- Radius Health, Inc.$316
- Amgen$290
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,02699%
- Education$140%
- Gifts$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 41 | $1,146 |
| Novo Nordisk | 76 | $918 |
| Lilly USA, LLC | 34 | $606 |
| Bayer | 24 | $316 |
| Radius Health, Inc. | 14 | $316 |
| Amgen(2 entities) | 18 | $290 |
| Sanofi-aventis U.S. LLC | 15 | $279 |
| Abbott | 9 | $187 |
| Mannkind Corporation | 9 | $167 |
| Boehringer Ingelheim | 10 | $148 |
| Genentech USA, Inc. | 1 | $100 |
| AbbVie | 6 | $89 |
| Intuity Medical Inc | 4 | $76 |
| Antares Pharma, Inc. | 4 | $67 |
| Xeris Pharmaceuticals, Inc. | 4 | $58 |
| Tandem Diabetes Care, Inc. | 3 | $55 |
| Novartis | 3 | $52 |
| Medtronic | 1 | $37 |
| BETA Bionics, Inc. | 2 | $30 |
| Edwards Lifesciences | 1 | $24 |
| Cequr Corporation | 1 | $23 |
| Exact Sciences | 1 | $21 |
| Amphastar Pharmaceuticals, Inc. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Tolmar, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,099 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $26,398 |
| TrulicityDulaglutide | 12 | $15,178 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 14 | $13,405 |
| HumalogInsulin Lispro | 12 | $2,553 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 18 | $1,452 |
| Atorvastatin Calcium | 71 | $1,304 |
| SynthroidLevothyroxine Sodium | 11 | $1,209 |
| Losartan Potassium | 27 | $783 |
| Rosuvastatin Calcium | 17 | $610 |
| Metformin Hcl ErMetformin Hcl | 28 | $559 |
| Metformin Hcl | 39 | $505 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $470 |
| Tamsulosin Hcl | 11 | $386 |
| Amlodipine Besylate | 22 | $253 |
| Fluticasone Propionate | 18 | $224 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $918 | $26,39819 claims |
| Lilly USA, LLCTrulicity, Humalog | $606 | $17,73124 claims |
| AbbVieSynthroid | $89 | $1,20911 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $19 | $20638 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 15,456 family providers in Texas.
Other family in Pasadena
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.